Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Sterling Financial Corp. (NASD: STSA) were yielding above the 3% mark based on its quarterly dividend ...

Forbes contributors publish independent expert analyses and insights. We provide aggregated data on dividend stocks. Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar ...

Satsuma Pharmaceuticals (STSA) closed the last trading session at $6.40, gaining 41.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Insiders who bought Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$3.5m as a result of the stock's ...

If you were to ask many of your fellow readers, hedge funds are perceived as bloated, old financial tools of a forgotten age. Although there are more than 8,000 hedge funds trading currently, Insider ...

Sterling Financial Corporation (NASDAQ:STSA) investors should pay attention to an increase in hedge fund sentiment in recent months. According to most market participants, hedge funds are seen as ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) to Shin Nippon Biomedical Laboratories, Ltd.